全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

非霍奇金淋巴瘤骨髓受累的诊断技术与预后评估

DOI: 10.3971/j.issn.1000-8578.2018.18.0061

Keywords: A Case Report and Literature Review,Mediastinal and Left Lung Malignancy Coupling with Suspicion for Esophagus Cancer: A Case Report,Clinical Features and Prognostic Factors of Primary Gastrointestinal Non-Hodgkin's Lymphoma,Successful Salvage Therapy with ABVD on Refractory Diffuse Large B-cell Lymphoma: A Case Report,Current Research Status of NF-kappa B Related Molecular Pathway in Diffuse Large B Cell Lymphoma,Expression of Toll-like Receptor 4 in Lymphoma Cell Lines and Its Effect on Cells Proliferation and Drug Resistance,Clinical Characteristics and Prognosis of 123 Patients with Diffuse Large B-cell Lymphoma of Waldeyer’s Ring,Differences of Clinical Features and Short-term Efficacy Between Diffuse Large B-cell Lymphomas of HIV-infected and Non-HIV-infected Patients

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要 骨髓受累(bone marrow involvement, BMI)是非霍奇金淋巴瘤不良预后的标志,因其在评估预后和指导治疗中举足轻重的地位,而成为非霍奇金淋巴瘤(NHL)初诊时必备的评估内容。在其检出手段中,骨髓活检(bone marrow biopsy, BMB)具备基石的地位,但随着抽吸物的流式细胞学技术、细胞遗传学技术以及分子生物学技术等技术进步,其诊断意义也在提升,并展现出评估预后的价值。同时,PET-CT作为一种有效的检出方法,也逐渐成为研究热点。本文将综述这些检出方法,同时对BMI新近的预后研究进行回顾,以展望其研究前景

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133